Loading...
Symbols:
Loading...
Symbols:
Clarient, Inc. (CLRT)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Clarient, Inc. (CLRT)
13 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on CLRT
- Douglas Cress(6)
- Alan Brochstein(5)
- Mike Havrilla(1)
- The Mole (1)
Most popular authors
(tracked in watchlists)
- Alan Brochstein(119)
- Mike Havrilla(84)
- The Mole (19)
- Douglas Cress(14)
Most commented on authors
- Alan Brochstein(15)
- Mike Havrilla(2)
- Douglas Cress(0)
- The Mole (0)
- Today's Market Moving Stories: Election Day
- Clarient: With Quarterly Revenues Up 59%, Take a Look
- Clarient Adds New Tool to Screen Biomarkers
- Clarient: Clearly a Winner
- Interview with Jim Datin, Executive VP & Managing Director of Safeguard Scientifics
- Interview with Ron Andrews, President & CEO of Clarient
- CombiMatrix and Clarient Partner to Market a More Sophisticated Cancer Test
- Clarient, Inc.: Clarifying the Complexities of Cancer
- Cancer Stocks Hammered Once Again
- Cancer Stocks Slide Again
- Cancer Stocks Plunge Following ASCO Meeting
- Cancer Stocks Soar With Annual ASCO Meeting
- Cancer Stocks on the Go: Winners and Losers
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »